Study shows cholesterol-lowering drug reduces diabetic retinopathy risk
An estimated 27% of patients globally living with diabetes will be affected by retinopathy
Read More
Tag: LENS
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
